Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation

Cell Death and Disease

Volumn 1, Issue 9, 2010, Pages

  Barton, C E ^a,b,c   Johnson, K N ^b,c   Mays, D M ^b,c   Boehnke, K ^d   Shyr, Y ^c   Boukamp, P ^d   Pietenpol, J A ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cytokines; FGF10; GM CSF; KGF; P53; P73

Indexed keywords

ACTIN; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ARTEMIN; BASAL CELL ADHESION MOLECULE PROTEIN; BETA TUBULIN; CLAUDIN 1; CYTOKERATIN 2; FIBROBLAST GROWTH FACTOR 10; FILAGGRIN; GLUCOSE TRANSPORTER 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INVOLUCRIN; JAGGED1; LORICRIN; METASTASIS SUPPRESSOR 1 PROTEIN; METAXIN 1; OXYSTEROL BINDING PROTEIN LIKE 3; P CADHERIN; PROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P63; PROTEIN P73; S100A2 PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; STRATIFIN; TRANSCRIPTION FACTOR RUNX1; TRISTETRAPROLIN; UNCLASSIFIED DRUG; UVOMORULIN; SMALL INTERFERING RNA; TCF7L1 PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 1; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; EPIDERMIS CELL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE TARGETING; HUMAN; HUMAN CELL; KERATINOCYTE; PARACRINE SIGNALING; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RNA INTERFERENCE;

BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1ALPHA; KERATINOCYTES; PARACRINE COMMUNICATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR 7-LIKE 1 PROTEIN; TUMOR SUPPRESSOR PROTEINS;

EID: 79958279335     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.49     Document Type: Article

References (40)

1. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-718. (Pubitemid 29197650)
2. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-713. (Pubitemid 29197649)
3. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 2003; 23: 2264-2276. (Pubitemid 36351010)
4. Barbieri CE, Tang LJ, Brown KA, Pietenpol JA. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 2006; 66: 7589-7597. (Pubitemid 44289215)
5. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006; 8: 551-561. (Pubitemid 43827347)
6. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominantnegative activities. Mol Cell 1998; 2: 305-316. (Pubitemid 128379271)
7. King KE, Ponnamperuma RM, Yamashita T, Tokino T, Lee LA, Young MF et al. DeltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 2003; 22: 3635-3644. (Pubitemid 36765323)
8. Helton ES, Zhu J, Chen X. The unique NH2-terminally deleted (deltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the deltaN variant of p63. J Biol Chem 2006; 281: 2533-2542. (Pubitemid 43845713)
9. Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999; 99: 143-153. (Pubitemid 29491781)
10. McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR et al. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet 2001; 10: 221-229. (Pubitemid 32123980)
11. Li N, Singh S, Cherukuri P, Li H, Yuan Z, Ellisen LW et al. Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells (Dayton, OH) 2008; 26: 1253-1264.
12. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18: 126-131. (Pubitemid 38141780)
13. Barbieri CE, Perez CA, Johnson KN, Ely KA, Billheimer D, Pietenpol JA. IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. Cancer Res 2005; 65: 2314-2320. (Pubitemid 40490141)
14. Testoni B, Borrelli S, Tenedini E, Alotto D, Castagnoli C, Piccolo S et al. Identification of new p63 targets in human keratinocytes. Cell Cycle 2006; 5: 2805-2811. (Pubitemid 44901743)
15. Perez CA, Ott J, Mays DJ, Pietenpol JA. p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm. Oncogene 2007; 26: 7363-7370. (Pubitemid 350115981)
16. Ortt K, Raveh E, Gat U, Sinha S. A chromatin immunoprecipitation screen in mouse keratinocytes reveals Runx1 as a direct transcriptional target of DeltaNp63. J Cell Biochem 2008; 104: 1204-1219. (Pubitemid 351961695)
17. Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, Gingeras TR et al. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 2006; 24: 593-602. (Pubitemid 350284225)
18. Vigano MA, Lamartine J, Testoni B, Merico D, Alotto D, Castagnoli C et al. New p63 targets in keratinocytes identified by a genome-wide approach. EMBO J 2006; 25: 5105-5116. (Pubitemid 44658528)
19. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006; 20: 3185-3197. (Pubitemid 44790632)
20. Labhart P, Karmakar S, Salicru EM, Egan BS, Alexiadis V, O'Malley BW et al. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc Natl Acad Sci USA 2005; 102: 1339-1344. (Pubitemid 40214365)
21. Rosenbluth JM, Mays DJ, Pino MF, Tang LJ, Pietenpol JA. A gene signature-based approach identifies mTOR as a regulator of p73. Mol Cell Biol 2008; 28: 5951-5964.
22. Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S et al. Mutant p53 drives invasion by promoting integrin recycling. Cell 2009; 139: 1327-1341.
23. Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B et al. A mutant-p53/ Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 2009; 137: 87-98.
24. Candi E, Rufini A, Terrinoni A, Dinsdale D, Ranalli M, Paradisi A et al. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 2006; 13: 1037-1047.
25. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000; 97: 5462-5467. (Pubitemid 30313741)
26. Toruner GA, Ulger C, Alkan M, Galante AT, Rinaggio J, Wilk R et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 2004; 154: 27-35. (Pubitemid 39286169)
27. O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005; 24: 1244-1251. (Pubitemid 40313925)
28. Maas-Szabowski N, Fusenig NE. Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 1996; 107: 849-855. (Pubitemid 26408203)
29. Maas-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 1999; 112 (Part 12): 1843-1853. (Pubitemid 29338810)
30. Aaronson SA, Rubin JS, Finch PW, Wong J, Marchese C, Falco J et al. Growth factorregulated pathways in epithelial cell proliferation. Am Rev Resp Dis 1990; 142 (Part 2): S7-10.
31. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 1990; 144: 326-332.
32. Merrill BJ, Gat U, DasGupta R, Fuchs E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 2001; 15: 1688-1705. (Pubitemid 32702590)
33. Nguyen H, Rendl M, Fuchs E. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 2006; 127: 171-183. (Pubitemid 44466637)
34. Candi E, Rufini A, Terrinoni A, Giamboi-Miraglia A, Lena AM, Mantovani R et al. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci USA 2007; 104: 11999-12004. (Pubitemid 47185619)
35. Shen CS, Tsuda T, Fushiki S, Mizutani H, Yamanishi K. The expression of p63 during epidermal remodeling in psoriasis. J Dermatol 2005; 32: 236-242. (Pubitemid 40745755)
36. Kovacs D, Falchi M, Cardinali G, Raffa S, Carducci M, Cota C et al. Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis. Exp Dermatol 2005; 14: 130-137. (Pubitemid 40277580)
37. Merrill BJ, Pasolli HA, Polak L, Rendl M, Garcia-Garcia MJ, Anderson KV et al. Tcf3: a transcriptional regulator of axis induction in the early embryo. Development (Cambridge, UK) 2004; 131: 263-274. (Pubitemid 38181367)
38. Barton CE, Tahinci E, Barbieri CE, Johnson KN, Hanson AJ, Jernigan KK et al. DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis. Dev Biol 2009; 329: 130-139.
39. Muffler S, Stark HJ, Amoros M, Falkowska-Hansen B, Boehnke K, Buhring HJ et al. A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures. Stem Cells (Dayton, OH) 2008; 26: 2506-2515.
40. Cerezo A, Stark HJ, Moshir S, Boukamp P. Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 2003; 121: 110-119. (Pubitemid 36900462)